Publication

Annual Patient Time Costs Associated With Medical Care Among Cancer Survivors in the United States

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    K. Robin Yabroff, Emory UniversityGery P. Guy, Jr., Centers for Disease Control and PreventionDonatus U. Ekwueme, Centers for Disease Control and PreventionTimothy McNeel, Information Management Services, IncHeather M. Rozjabek, National Cancer InstituteEmily Dowling, Massachusetts General HospitalChunyu Li, Centers for Disease Control and PreventionKatherine S Virgo, Emory University
Language
  • English
Date
  • 2014-07-01
Publisher
  • Lippincott, Williams & Wilkins
Publication Version
Copyright Statement
  • Copyright © 2014 by Lippincott Williams & Wilkins.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0025-7079
Volume
  • 52
Issue
  • 7
Start Page
  • 594
End Page
  • 601
Grant/Funding Information
  • The non-Federal collaborators volunteered their time on this project.
  • This analysis was led by Federal employees with no external source of support for the work.
Supplemental Material (URL)
Abstract
  • BACKGROUND: Although patient time costs are recommended for inclusion in cost-effectiveness analyses, these data are not routinely collected. We used nationally representative data and a medical service-based approach to estimate the annual patient time costs among cancer survivors. METHODS: We identified adult 6699 cancer survivors and 86,412 individuals without a cancer history ages 18 years or more from 2008-2011 Medical Expenditure Panel Survey (MEPS). Service use was categorized as hospitalizations, emergency room use, provider visits, ambulatory surgery, chemotherapy, and radiation therapy. Service time estimates were applied to frequencies for each service category and the US median wage rate in 2011 was used to value time. We evaluated the association between cancer survivorship and service use frequencies and patient time costs with multivariable regression models, stratified by age group (18-64 and 65+ y). Sensitivity analyses evaluated different approaches for valuing time. RESULTS: Cancer survivors were more likely to have hospitalizations, emergency room visits, ambulatory surgeries, and provider visits in the past year than individuals without a cancer history in adjusted analyses (P<0.05). Annual patient time was higher for cancer survivors than individuals without a cancer history among those aged 18-64 years (30.2 vs. 13.6 h; P<0.001) and 65+ years (55.1 vs. 36.6 h; P<0.001), as were annual patient time costs (18-64 y: $500 vs. $226; P<0.001 and 65+ y: $913 vs. $607; P<0.001). CONCLUSIONS: Cancer survivors had greater annual medical service use and patient time costs than individuals without a cancer history. This medical service-based approach for estimating annual time costs can also be applied to other conditions.
Author Notes
  • Address correspondence to: K. Robin Yabroff, PhD, Health Services and Economics Branch, National Cancer Institute, 9609 Medical Center Drive 3E436, Rockville, MD 20850, yabroffr@mail.nih.gov
Keywords
Research Categories
  • Health Sciences, Health Care Management
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items